Hällqvist, Jenny https://orcid.org/0000-0001-6709-3211
Bartl, Michael https://orcid.org/0000-0002-7752-2443
Dakna, Mohammed
Schade, Sebastian https://orcid.org/0000-0002-6316-6804
Garagnani, Paolo https://orcid.org/0000-0002-4161-3626
Bacalini, Maria-Giulia
Pirazzini, Chiara
Bhatia, Kailash https://orcid.org/0000-0001-8185-286X
Schreglmann, Sebastian https://orcid.org/0000-0002-4129-5808
Xylaki, Mary https://orcid.org/0000-0002-7892-8621
Weber, Sandrina
Ernst, Marielle
Muntean, Maria-Lucia
Sixel-Döring, Friederike
Franceschi, Claudio https://orcid.org/0000-0001-9841-6386
Doykov, Ivan
Śpiewak, Justyna
Vinette, Héloїse https://orcid.org/0009-0000-4360-1293
Trenkwalder, Claudia
Heywood, Wendy E. https://orcid.org/0000-0003-2106-8760
Mills, Kevin
Mollenhauer, Brit https://orcid.org/0000-0001-8437-3645
Article History
Received: 6 April 2023
Accepted: 20 May 2024
First Online: 18 June 2024
Competing interests
: JH, MD, MX, SW, KB, ME, PG, MGB, CP, KM, ID, WH, JS, HV and CF and have no competing interests to report. MB has received funding from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – 413,501,650. CT has received honoraria for consultancy from Roche, and honoraria for educational lectures from UCB, and has received research funding for the PPMI study from the Michael J. Fox Foundation and funding from the EU (Horizon 2020) and stipends from the (International Parkinson’s and Movement Disorder Society) IPMDS. BM has received honoraria for consultancy from Roche, Biogen, AbbVie, UCB, and Sun Pharma Advanced Research Company. BM is a member of the executive steering committee of the Parkinson Progression Marker Initiative and PI of the Systemic Synuclein Sampling Study of the Michael J. Fox Foundation for Parkinson’s Research and has received research funding from the Deutsche Forschungsgemeinschaft (DFG), EU (Horizon 2020), Parkinson Fonds Deutschland, Deutsche Parkinson Vereinigung, Parkinson’s Foundation and the Michael J. Fox Foundation for Parkinson’s Research. MLM has received honoraria for speaking engagements from Deutsche Parkinson Gesellschaft e.V., and royalties from Gesellschaft fur Medien + Kommunikation mbH + Co. FSD has received honoraria for speaking engagements from AbbVie, Bial, Ever Pharma, Medtronic and royalties from Elsevier and Springer. She served on an advisory board for Zambon and Stada Pharma. FSD participated in Ad Boards for consultation: Abbvie, UCB, Bial, Ono, Roche and got honorary for lecturing: Stada Pharm, AbbVie, Alexion, Bial. S. Schade received institutional salaries supported by the EU Horizon 2020 research and innovation programme under grant agreement No. 863664 and by the Michael J. Fox Foundation for Parkinson’s Research under grant agreement No. MJFF-021923. He is supported by a PPMI Early Stage Investigators Funding Programme fellowship of the Michael J. Fox Foundation for Parkinson’s Research under grant agreement No. MJFF-022656. S. Schreglmann received institutional salaries supported by the EU Horizon 2020 research and innovation programme under grant agreement No. 863664, support from the Advanced Clinician Scientist programme by the Interdisciplinary Centre for Clinical Research, Wuerzburg, Germany, and from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Project-ID 424778381-TRR 295. He is a fellow of the Thiemann Foundation. He serves as a scientific adviser to Elemind Inc.